tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Ironwood Pharmaceuticals Reports Strong Q3 2025 Earnings
Company AnnouncementsIronwood Pharmaceuticals Reports Strong Q3 2025 Earnings
2d ago
IRWD
Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
PremiumThe Fly
Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
2d ago
JD
CNC
Ironwood reports Q3 EPS 24c, consensus 12c
PremiumThe Fly
Ironwood reports Q3 EPS 24c, consensus 12c
2d ago
IRWD
Ironwood raises FY25 revenue view to $290M-$310M from $260M-$290M
PremiumThe Fly
Ironwood raises FY25 revenue view to $290M-$310M from $260M-$290M
2d ago
IRWD
FDA approves Ironwood’s Linzess for IBS-C in pediatric patients
PremiumThe Fly
FDA approves Ironwood’s Linzess for IBS-C in pediatric patients
7d ago
IRWD
Ironwood Pharmaceuticals (IRWD) Q3 Earnings Cheat Sheet
PremiumPre-EarningsIronwood Pharmaceuticals (IRWD) Q3 Earnings Cheat Sheet
9d ago
IRWD
Ironwood jumps after AbbVie reports Linzess sales beat
Premium
The Fly
Ironwood jumps after AbbVie reports Linzess sales beat
12d ago
ABBV
IRWD
Ironwood Pharma Board Member Resigns for New Role
Premium
Company Announcements
Ironwood Pharma Board Member Resigns for New Role
1M ago
8K
IRWD
Ironwood Pharma Regains Nasdaq Compliance
PremiumCompany Announcements
Ironwood Pharma Regains Nasdaq Compliance
2M ago
8K
IRWD
Ironwood Pharmaceuticals Reports Strong Q2 2025 Results
PremiumCompany Announcements
Ironwood Pharmaceuticals Reports Strong Q2 2025 Results
3M ago
IRWD
Ironwood Pharmaceuticals (IRWD) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Ironwood Pharmaceuticals (IRWD) Q2 Earnings Cheat Sheet
3M ago
IRWD
Ironwood Pharma Elects Directors at Annual Meeting
PremiumCompany Announcements
Ironwood Pharma Elects Directors at Annual Meeting
5M ago
8K
IRWD
Ironwood Pharma Receives Nasdaq Deficiency Letter
PremiumCompany AnnouncementsIronwood Pharma Receives Nasdaq Deficiency Letter
5M ago
8K
IRWD
Ironwood Pharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
Ironwood Pharmaceuticals Reports Q1 2025 Financial Results
6M ago
IRWD
Ironwood reports Q1 EPS (14c), two estimates (3c)
Premium
The Fly
Ironwood reports Q1 EPS (14c), two estimates (3c)
6M ago
IRWD
Ironwood affirms FY25 revenue $260M-$290M, consensus $286.8M
PremiumThe Fly
Ironwood affirms FY25 revenue $260M-$290M, consensus $286.8M
6M ago
IRWD
Ironwood Pharma: Hold Rating Maintained Amid Revenue Uncertainty and Long-term Concerns
PremiumRatings
Ironwood Pharma: Hold Rating Maintained Amid Revenue Uncertainty and Long-term Concerns
7M ago
IRWD
IRWD Earnings this Week: How Will it Perform?
PremiumPre-Earnings
IRWD Earnings this Week: How Will it Perform?
7M ago
IRWD
Ironwood backs FY25 revenue view $260M-$290M, consensus $287.07M
PremiumThe Fly
Ironwood backs FY25 revenue view $260M-$290M, consensus $287.07M
7M ago
IRWD
Ironwood downgraded to Hold from Buy at Craig-Hallum
PremiumThe FlyIronwood downgraded to Hold from Buy at Craig-Hallum
7M ago
IRWD
Ironwood Pharma: Hold Rating Amid Uncertainty Over Apraglutide’s Phase 3 Trial and Strategic Options
Premium
Ratings
Ironwood Pharma: Hold Rating Amid Uncertainty Over Apraglutide’s Phase 3 Trial and Strategic Options
7M ago
IRWD
Ironwood downgraded to Hold from Buy at Jefferies
Premium
The Fly
Ironwood downgraded to Hold from Buy at Jefferies
7M ago
IRWD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >